Estco Medical Launches New Web Site for MacroGenics
Estco Medical today announced the launch of a new web site for MacroGenics at www.macrogenics.com.
Bethesda, MD (PRWEB) June 14, 2005 -- Estco Medical today announced the
launch of a new web site for MacroGenics at www.macrogenics.com. Based in Rockville, Maryland, MacroGenics
is a biotechnology company focused on the development of therapeutic antibodies
to treat patients with cancer, autoimmune disorders, allergy, and infectious
diseases and vaccines to prevent infections in healthy individuals. The new site
serves to track the progress of MacroGenics’ product portfolio and proprietary
technology platforms.
MacroGenics consulted Estco Medical to design a
professional site and to develop an online information center that provides
up-to-date content for biotech professionals, collaborators, researchers,
investors, and potential employees. Estco created a graphic design and site
structure that portrays the company’s product development strategy and powered
the site with Medigent CMS to easily administer updates to the evolving content.
The information architecture was developed to provide primary background
content and media relations as well as site specific sections about MacroGenics'
product pipeline. Estco also developed an interactive illustration of
MacroGenics’ Fc receptor technology for the site which can easily be
incorporated for presentation purposes.
"The web site not only looks
professional, but nicely depicts our product focus in a descriptive and
informative manner. The seamless integration with Medigent CMS allows each
department to manage their respective site areas to monitor and maintain
corporate updates," said Michael Richman, Chief Operating Officer of
MacroGenics.
About MacroGenics, Inc.
MacroGenics is a privately funded
company focused on the development and manufacture of biotechnology products
including immunotherapeutics for cancer, infectious diseases and autoimmune
disorders. MacroGenics' core platform involves antibody Fc receptor-related
technologies, which are employed to improve the ways cytotoxic antibody mediate
cell killing for the treatment of cancers and to prevent autoantibody from
triggering disease in autoimmunity. For more information, visit www.macrogenics.com.
About Estco Medical
Founded in
Bethesda, MD in 1999, Estco Medical is the creator of the web-based Medigent®
software suite, which aids pharmaceutical, medical device, biotech and other
life science companies in launching and managing online marketing initiatives.
GE Healthcare, Medtronic, Aspect Medical Systems, the Cleveland Clinic, and
leading pharmaceutical and medical device manufacturers are among the life
science companies using the Medigent software suite to better communicate,
educate and validate processes through every part of a product marketing life
cycle. The Medigent software suite includes components for content management,
media and investor relations, product and clinical education, community
development and outcomes and market research studies. For more information,
visit www.estcomedical.com or call 301-657-9332.
Press
Contact:
John Estafanous, President
Estco Medical
e-mail protected from
spam bots
301-657-9332 x23
# # #
Source : http://www.prweb.com/releases/2005/6/prweb250236.htm